Kidney bioengineering in regenerative medicine: An emerging therapy for kidney disease.
Cytotherapy
; 18(2): 186-97, 2016 Feb.
Article
en En
| MEDLINE
| ID: mdl-26596504
The prevalence of end-stage renal disease is emerging as a serious worldwide public health problem because of the shortage of donor organs and the need to take lifelong immunosuppressive medication in patients who receive a transplanted kidney. Recently, tissue bioengineering of decellularization and recellularization scaffolds has emerged as a novel strategy for organ regeneration, and we review the critical technologies supporting these methods. We present a summary of factors associated with experimental protocols that may shed light on the future development of kidney bioengineering and we discuss the cell sources and bioreactor techniques applied to the recellularization process. Finally, we review some artificial renal engineering technologies and their future prospects, such as kidney on a chip and the application of three-dimensional and four-dimensional printing in kidney tissue engineering.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Regeneración
/
Ingeniería de Tejidos
/
Medicina Regenerativa
/
Regeneración Tisular Dirigida
/
Fallo Renal Crónico
Tipo de estudio:
Risk_factors_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Cytotherapy
Asunto de la revista:
TERAPEUTICA
Año:
2016
Tipo del documento:
Article
País de afiliación:
China